Powering
Smarter Treatments and Healthier People 

Managing clinical research demands more than disconnected systems; it requires an intelligent platform that links Study, Patient, and Data Experiences.

Why Experiences

Discover how early AI adoption is transforming every stage of the trial lifecycle in our 2nd annual State of AI in Clinical Trials report.

Why Medidata

Chosen Technology

0 %

of FDA novel drug
approvals used Medidata

in 2025

TRUSTED IN

0 K+

clinical trials

AI FOR IMPACT BUILT ON

0 B

data points annually

USED BY

0 M+

patients

Trusted by Sponsors and CROs Across Therapeutic Areas.

Real Impact across Every Role

Data

 
Video thumbnail

ICON Accelerates Decision-Making with Real-Time, Unified Data Review

We chose [Clinical Data Studio] as our single data platform for ALL of our cross-functional review. From traditional data management, to central monitoring, and our medical review all in one platform. Because we have to be efficient and we have to be fast. We need to perform real-time data review early in the study to be able to get those insights to be able to help our sponsors make go/no-go decisions as needed.

Evan Hughes

VP Data Management

Awards and Recognition

The Latest

New. Now. Noteworthy.
Discover the breakthroughs shaping what's next.

Go to Newsroom

Medidata Champions Real-World AI with Medidata Plus at NEXT Tokyo 2026 to Accelerate Life-Saving Patient Therapies

Medidata Launches Medidata Plus, an AI-Native Foundation Built to Scale Clinical Portfolios

Medidata expands Site Insights Program to Include Academic Perspective and Drive New Site-Centric Solutions

R&G PharmaStudies Expands Partnership with Medidata, Deploying the Medidata Data Experience to Elevate Trial Quality and Accelerate Global Therapies